Report cover image

Uncomplicated Urinary Tract Infection Global Market Report 2025

Published Jun 17, 2025
Length 175 Pages
SKU # BRC20111202

Description

Uncomplicated Urinary Tract Infection Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on uncomplicated urinary tract infection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for uncomplicated urinary tract infection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The uncomplicated urinary tract infection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Test Type: Urinalysis; Urine Cultures; Susceptibility Testing

2) By Drug: Penicillin And Combinations; Quinolones; Cephalosporin; Azoles And Amphotericin B; Nitrofurans; Other Drugs

3) By End-Users: Hospitals; Diagnostic Labs; Research Institutes

Subsegments:

1) By Urinalysis: Dipstick Tests; Microscopic Examination; Automated Urinalysis

2) By Urine Cultures: Agar Plate Culture; Broth Culture; Chromogenic Media

3) By Susceptibility Testing: Disk Diffusion Method; Automated Susceptibility Testing; Molecular Susceptibility Testing

Companies Mentioned: Cardinal Health; Pfizer Inc.; Bayer AG; AstraZeneca plc; GSK plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Uncomplicated Urinary Tract Infection Market Characteristics
3. Uncomplicated Urinary Tract Infection Market Trends And Strategies
4. Uncomplicated Urinary Tract Infection Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Uncomplicated Urinary Tract Infection Growth Analysis And Strategic Analysis Framework
5.1. Global Uncomplicated Urinary Tract Infection PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Uncomplicated Urinary Tract Infection Market Growth Rate Analysis
5.4. Global Uncomplicated Urinary Tract Infection Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Uncomplicated Urinary Tract Infection Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Uncomplicated Urinary Tract Infection Total Addressable Market (TAM)
6. Uncomplicated Urinary Tract Infection Market Segmentation
6.1. Global Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urinalysis
Urine Cultures
Susceptibility Testing
6.2. Global Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Penicillin And Combinations
Quinolones
Cephalosporin
Azoles And Amphotericin B
Nitrofurans
Other Drugs
6.3. Global Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Labs
Research Institutes
6.4. Global Uncomplicated Urinary Tract Infection Market, Sub-Segmentation Of Urinalysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dipstick Tests
Microscopic Examination
Automated Urinalysis
6.5. Global Uncomplicated Urinary Tract Infection Market, Sub-Segmentation Of Urine Cultures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Agar Plate Culture
Broth Culture
Chromogenic Media
6.6. Global Uncomplicated Urinary Tract Infection Market, Sub-Segmentation Of Susceptibility Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Disk Diffusion Method
Automated Susceptibility Testing
Molecular Susceptibility Testing
7. Uncomplicated Urinary Tract Infection Market Regional And Country Analysis
7.1. Global Uncomplicated Urinary Tract Infection Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Uncomplicated Urinary Tract Infection Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Uncomplicated Urinary Tract Infection Market
8.1. Asia-Pacific Uncomplicated Urinary Tract Infection Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Uncomplicated Urinary Tract Infection Market
9.1. China Uncomplicated Urinary Tract Infection Market Overview
9.2. China Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Uncomplicated Urinary Tract Infection Market
10.1. India Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Uncomplicated Urinary Tract Infection Market
11.1. Japan Uncomplicated Urinary Tract Infection Market Overview
11.2. Japan Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Uncomplicated Urinary Tract Infection Market
12.1. Australia Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Uncomplicated Urinary Tract Infection Market
13.1. Indonesia Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Uncomplicated Urinary Tract Infection Market
14.1. South Korea Uncomplicated Urinary Tract Infection Market Overview
14.2. South Korea Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Uncomplicated Urinary Tract Infection Market
15.1. Western Europe Uncomplicated Urinary Tract Infection Market Overview
15.2. Western Europe Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Uncomplicated Urinary Tract Infection Market
16.1. UK Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Uncomplicated Urinary Tract Infection Market
17.1. Germany Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Uncomplicated Urinary Tract Infection Market
18.1. France Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Uncomplicated Urinary Tract Infection Market
19.1. Italy Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Uncomplicated Urinary Tract Infection Market
20.1. Spain Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Uncomplicated Urinary Tract Infection Market
21.1. Eastern Europe Uncomplicated Urinary Tract Infection Market Overview
21.2. Eastern Europe Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Uncomplicated Urinary Tract Infection Market
22.1. Russia Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Uncomplicated Urinary Tract Infection Market
23.1. North America Uncomplicated Urinary Tract Infection Market Overview
23.2. North America Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Uncomplicated Urinary Tract Infection Market
24.1. USA Uncomplicated Urinary Tract Infection Market Overview
24.2. USA Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Uncomplicated Urinary Tract Infection Market
25.1. Canada Uncomplicated Urinary Tract Infection Market Overview
25.2. Canada Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Uncomplicated Urinary Tract Infection Market
26.1. South America Uncomplicated Urinary Tract Infection Market Overview
26.2. South America Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Uncomplicated Urinary Tract Infection Market
27.1. Brazil Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Uncomplicated Urinary Tract Infection Market
28.1. Middle East Uncomplicated Urinary Tract Infection Market Overview
28.2. Middle East Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Uncomplicated Urinary Tract Infection Market
29.1. Africa Uncomplicated Urinary Tract Infection Market Overview
29.2. Africa Uncomplicated Urinary Tract Infection Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Uncomplicated Urinary Tract Infection Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Uncomplicated Urinary Tract Infection Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Uncomplicated Urinary Tract Infection Market Competitive Landscape And Company Profiles
30.1. Uncomplicated Urinary Tract Infection Market Competitive Landscape
30.2. Uncomplicated Urinary Tract Infection Market Company Profiles
30.2.1. Cardinal Health Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
30.2.5. GSK plc Overview, Products and Services, Strategy and Financial Analysis
31. Uncomplicated Urinary Tract Infection Market Other Major And Innovative Companies
31.1. Eli Lilly and Company
31.2. Siemens AG
31.3. Strykar Healthcare
31.4. John Hopkins Medicine
31.5. Shionogi & Co. Ltd.
31.6. Sysmex Corporation
31.7. Bio-Rad Laboratories Inc
31.8. Cipla Inc.
31.9. UTILITY therapeutics Ltd
31.10. Orchid Pharma Limited
31.11. ACON Labs
31.12. Sonika Lifesciences
31.13. Emergency Care BC
31.14. EB Medicine
31.15. Iterum Therapeutics PLC
32. Global Uncomplicated Urinary Tract Infection Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Uncomplicated Urinary Tract Infection Market
34. Recent Developments In The Uncomplicated Urinary Tract Infection Market
35. Uncomplicated Urinary Tract Infection Market High Potential Countries, Segments and Strategies
35.1 Uncomplicated Urinary Tract Infection Market In 2029 - Countries Offering Most New Opportunities
35.2 Uncomplicated Urinary Tract Infection Market In 2029 - Segments Offering Most New Opportunities
35.3 Uncomplicated Urinary Tract Infection Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.